Development of a chemically stable 10-hydroxycamptothecin nanosuspensions

被引:138
作者
Pu, Xiaohui [1 ]
Sun, Jin [1 ]
Wang, Yan [1 ]
Wang, Yongjun [1 ]
Liu, Xiaohong [1 ]
Zhang, Peng [1 ]
Tang, Xing [1 ]
Pan, Weisan [1 ]
Han, Jihong [2 ,3 ]
He, Zhonggui [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, Dept Biopharmaceut, Shenyang 110016, Peoples R China
[2] Univ Keele, Sch Pharm, Keele ST5 5BG, Staffs, England
[3] Univ Keele, Inst Sci & Techno Med, Keele ST5 5BG, Staffs, England
关键词
Anticancer drugs; 10-Hydroxycamptothecin; Nanosuspensions; Microprecipitation-high-pressure homogenization; Chemical stability improvement; HIGH-PRESSURE HOMOGENIZATION; POORLY SOLUBLE DRUGS; CONTROLLED PRECIPITATION; LOADED NANOPARTICLES; ANTITUMOR-ACTIVITY; DISSOLUTION; STABILIZATION; MICROSPHERES; EMULSIONS; NIOSOMES;
D O I
10.1016/j.ijpharm.2009.05.062
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The purpose of this study was to prepare and characterize nanosuspensions loading the active lactone form of 10-hydroxycamptothecin (10-HCPT). Nanosuspensions were prepared in terms of microprecipitation-high-pressure homogenization method. As for the preparation processes, three important parameters, i.e. the agitation rate of stabilizer solution, homogenization pressure and cycle numbers, were investigated and optimized, and the optimal values were 1000 rpm, 1000 bar and 20 times, respectively. The particle size and zeta potential of the 10-HCPT-nanosus pensions were 131 nm and -25.5 mV. The particle morphology was determined by transmission electron microscopy and the 10-HCPT nanoparticles were baculine or trabecular in shape. The solid state of 10-HCPT in nanoparticles was analyzed using X-ray powder diffraction (XRD) and differential scanning calorimetry (DSC). The XRD and the DSC results both indicated that 10-HCPT was present as an amorphous state in the lyophilized powders for nanosuspension. The chemical stability tests demonstrated that near 90% lactone form of 10-HCPT was present in the nanosuspensions but it was easily transferred to the carboxylate form in the solution at pH 7.0-8.0. In vitro dissolution tests showed the dissolution rate of nanosuspensions, compared with the coarse suspensions, had been significantly increased. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 37 条
[1]
Synthesis of alginic acid-poly[2-(diethylamino)ethyl methacrylate] monodispersed nanoparticles by a polymer-monomer pair reaction system [J].
Guo, Rui ;
Zhang, Leyang ;
Jiang, Zhiping ;
Cao, Yi ;
Ding, Yin ;
Jiang, Xiqun .
BIOMACROMOLECULES, 2007, 8 (03) :843-850
[2]
HIGHLIGHT ON THE STUDIES OF ANTICANCER DRUGS DERIVED FROM PLANTS IN CHINA [J].
HAN, R .
STEM CELLS, 1994, 12 (01) :53-63
[3]
Synthesis and biological evaluation of bis and monocarbonate prodrugs of 10-hydroxycamptothecins [J].
He, XG ;
Lu, W ;
Jiang, XQ ;
Cai, JC ;
Zhang, XW ;
Ding, J .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (15) :4003-4008
[4]
Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin [J].
Hong, Minghuang ;
Zhu, Saijie ;
Jiang, Yanyan ;
Tang, Guotao ;
Pei, Yuanying .
JOURNAL OF CONTROLLED RELEASE, 2009, 133 (02) :96-102
[5]
HSIANG YH, 1985, J BIOL CHEM, V260, P4873
[6]
Production and characterization of a budesonide nanosuspension for pulmonary administration [J].
Jacobs, C ;
Müller, RH .
PHARMACEUTICAL RESEARCH, 2002, 19 (02) :189-194
[7]
Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs [J].
Kocbek, P ;
Baumgartner, S ;
Kristl, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 312 (1-2) :179-186
[8]
Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation [J].
Krause, KP ;
Müller, RH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 214 (1-2) :21-24
[9]
Liu K, 2008, DRUG DEV IND PHARM, V34, P465, DOI [10.1080/03639040701662230, 10.1080/03639040701662230 ]
[10]
PARTICLE-SIZE REDUCTION FOR IMPROVEMENT OF ORAL BIOAVAILABILITY OF HYDROPHOBIC DRUGS .1. ABSOLUTE ORAL BIOAVAILABILITY OF NANOCRYSTALLINE DANAZOL IN BEAGLE DOGS [J].
LIVERSIDGE, GG ;
CUNDY, KC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 125 (01) :91-97